These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9973573)

  • 1. Thermodynamics of model prions and its implications for the problem of prion protein folding.
    Harrison PM; Chan HS; Prusiner SB; Cohen FE
    J Mol Biol; 1999 Feb; 286(2):593-606. PubMed ID: 9973573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational propagation with prion-like characteristics in a simple model of protein folding.
    Harrison PM; Chan HS; Prusiner SB; Cohen FE
    Protein Sci; 2001 Apr; 10(4):819-35. PubMed ID: 11274473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determinants of stability in the human prion protein: insights into folding and misfolding from the analysis of the change in the stabilization energy distribution in different conditions.
    Colacino S; Tiana G; Broglia RA; Colombo G
    Proteins; 2006 Mar; 62(3):698-707. PubMed ID: 16432880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
    Jackson GS; Hosszu LL; Power A; Hill AF; Kenney J; Saibil H; Craven CJ; Waltho JP; Clarke AR; Collinge J
    Science; 1999 Mar; 283(5409):1935-7. PubMed ID: 10082469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folding pathways of prion and doppel.
    Settanni G; Hoang TX; Micheletti C; Maritan A
    Biophys J; 2002 Dec; 83(6):3533-41. PubMed ID: 12496120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scrapie prions: a three-dimensional model of an infectious fragment.
    Huang Z; Prusiner SB; Cohen FE
    Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S; Glockshuber R
    J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theory of kinetic partitioning in protein folding with possible applications to prions.
    Abkevich VI; Gutin AM; Shakhnovich EI
    Proteins; 1998 Jun; 31(4):335-44. PubMed ID: 9626694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
    Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
    J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature.
    Martins SM; Chapeaurouge A; Ferreira ST
    J Biol Chem; 2003 Dec; 278(50):50449-55. PubMed ID: 14525996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling a prion protein dimer: predictions for fibril formation.
    Warwicker J
    Biochem Biophys Res Commun; 2000 Nov; 278(3):646-52. PubMed ID: 11095963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion strain mutation determined by prion protein conformational compatibility and primary structure.
    Angers RC; Kang HE; Napier D; Browning S; Seward T; Mathiason C; Balachandran A; McKenzie D; Castilla J; Soto C; Jewell J; Graham C; Hoover EA; Telling GC
    Science; 2010 May; 328(5982):1154-8. PubMed ID: 20466881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulation of dimeric and monomeric forms of human prion protein: insight into dynamics and properties.
    Sekijima M; Motono C; Yamasaki S; Kaneko K; Akiyama Y
    Biophys J; 2003 Aug; 85(2):1176-85. PubMed ID: 12885661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
    Singh J; Udgaonkar JB
    Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Unfolding chaperone as a prion protein relating molecule].
    Hachiya NS; Sakasegawa Y; Kaneko K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):817-9. PubMed ID: 15152473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.